Cargando…
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
Targeted therapies have allowed for an individualized treatment approach in non-small-cell lung cancer (NSCLC). The initial therapeutic decisions and success of targeted therapy depend on genetic identification of personal tumor profiles. Tissue biopsy is the gold standard for molecular analysis, bu...
Autores principales: | Saarenheimo, Jatta, Eigeliene, Natalja, Andersen, Heidi, Tiirola, Marja, Jekunen, Antti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411700/ https://www.ncbi.nlm.nih.gov/pubmed/30891428 http://dx.doi.org/10.3389/fonc.2019.00129 |
Ejemplares similares
-
Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review
por: Saarenheimo, Jatta, et al.
Publicado: (2021) -
Current challenges in applying gene-driven therapies in clinical lung cancer practice
por: Saarenheimo, Jatta, et al.
Publicado: (2021) -
Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment
por: Eigeliene, Natalja, et al.
Publicado: (2021) -
Functional gene pyrosequencing reveals core proteobacterial denitrifiers in boreal lakes
por: Saarenheimo, Jatta, et al.
Publicado: (2015) -
Microbial Community Response on Wastewater Discharge in Boreal Lake Sediments
por: Saarenheimo, Jatta, et al.
Publicado: (2017)